Phaim Pharma Ltd

Drug Discovery

Website: https://www.phaim.co.uk/
Membership category: Emerging Y3

PO Box 77323, London, SW15 9JA, United Kingdom

Phaim Pharma Ltd at a glance

Phaim develops disruptive and potentially curative therapies and prognostic markers for autoimmune disease via a platform approach of antigenic immunomodulation.

About Phaim Pharma Ltd

Phaim Pharma is dedicated to developing potentially curative treatments for auto-immune diseases. The company is developing a range of novel therapeutic innovations including an exciting new therapy to treat and prevent diabetes as well as a predictive biomarker kit for first-degree relatives. The long-term goal is the broadening of our platform approach to other autoimmune diseases, such as psoriasis, through our active R & D programme. Our team is dedicated on improving lives of people with diabetes and we are a UK based company working with world-class companies to deliver life-changing therapies.

Therapeutic area(s)

Immunology/inflammation
Diabetes
Platform Technology
Autoimmune diseases
Translational Medicine
Biomarkers

Articles Phaim Pharma Ltd has contributed to

15 November 2021

Guest Blog: Phaim Pharma - World Diabetes Day

World Diabetes Day, held on November 14th each year, is the primary global awareness campaign drawing attention to issues of paramount importance to the diabetes world. Phaim Pharma is focused on developing therapeutics and diagnostics for autoimmune disease via Antigenic ImmuneModulation (AIM). They have a flagship product in Type 1 Diabetes Mellitus (T1DM) which has the potential to arrest the disease process and be preventative.

Blog